Latest Jean Tang Stories

Doctors charged with treating patients with a rare form of one of the most common types of cancer in the US may have a new weapon for their fight after a clinical study has shown a particular drug has proven very effective in both the treatment and prevention of the disease. The new drug, vismodegib (or Erivedge™), has been found to dramatically shrink basal cell carcinoma (BCC) skin cancers and prevent the formation of new ones in patients with basal cell nevus syndrome (BCNS), or...

A combination of calcium and vitamin D may cut the chance of melanoma in half for some women at high risk of developing this life-threatening skin cancer, according to a new study by Stanford University School of Medicine researchers.Using existing data from a large clinical trial, the study zeroed in on women with a history of non-melanoma skin cancer, as people with this generally non-fatal disease are more likely to develop the more lethal illness "” melanoma. The researchers found that...

A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine. Although oral administration of the drug, celecoxib, is associated with an increased risk of heart attack and stroke in some people, it's possible that topical application could have a safer, protective effect for people prone to developing the cancers, called basal cell carcinomas, the researcher believes."Basal cell...